Equillium Inc. (EQ) is priced at $6.63 after the most recent trading session. At the very opening of the session, the stock price was $5.57 and reached a high price of $6.11, prior to closing the session it reached the value of $5.72. The stock touched a low price of $5.41.
Recently in News on September 15, 2020, Equillium Announces Successful Completion of FDA Pre-IND Meeting Enabling Advancement of Itolizumab into a Potential Registration Study as a Treatment for Hospitalized COVID-19 Patients. Equillium anticipates filing a U.S. IND for Itolizumab for COVID-19 and initiating a global Phase 3 clinical study in Q4 2020. You can read further details here
Equillium Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $27.05 on 07/13/20, with the lowest value was $2.20 for the same time period, recorded on 03/24/20.
Equillium Inc. (EQ) full year performance was 50.13%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Equillium Inc. shares are logging -75.51% during the 52-week period from high price, and 201.14% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.20 and $27.05.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2869697 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Equillium Inc. (EQ) recorded performance in the market was 69.23%, having the revenues showcasing 97.92% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 127.78M, as it employees total of 22 workers.
Specialists analysis on Equillium Inc. (EQ)
During the last month, 0 analysts gave the Equillium Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 5.91, with a change in the price was noted +4.07. In a similar fashion, Equillium Inc. posted a movement of +146.93% for the period of last 100 days, recording 1,765,417 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for EQ is recording 0.32 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.32.
Trends and Technical analysis: Equillium Inc. (EQ)
Raw Stochastic average of Equillium Inc. in the period of last 50 days is set at 17.21%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 82.63%. In the last 20 days, the company’s Stochastic %K was 49.06% and its Stochastic %D was recorded 29.86%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 69.23%. Additionally, trading for the stock in the period of the last six months notably improved by 136.36%, alongside a boost of 50.13% for the period of the last 12 months. The shares increased approximately by 13.04% in the 7-day charts and went up by -35.15% in the period of the last 30 days. Common stock shares were driven by 97.92% during last recorded quarter.